# Jasper Therapeutics, Inc.: Form DEF 14A, filed Sep 4, 2026

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: DEF 14A
- Filed: 2026-09-04
- Accepted by EDGAR: Sep 4, 2026, 15:08 ET
- Period: 2026-09-30
- Accession: 0001213900-26-097572
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026097572/ea0302959-02.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390026097572/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390026097572/ea0302959-02.htm

Filed Sep 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-097572. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
